NCT05652335 2026-03-13
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Janssen Research & Development, LLC
Phase 1 Recruiting
Janssen Research & Development, LLC
Alexion Pharmaceuticals, Inc.
Universitaire Ziekenhuizen KU Leuven